期刊文献+

携带丙型肝炎病毒非结构蛋白3基因的重组腺病毒构建研究 被引量:2

Construction of Recombinant Adenovirus Carrying Hepatitis C Virus Nonstructural Protein 3 Gene
下载PDF
导出
摘要 目的构建表达丙型肝炎病毒(HCV)非结构蛋白3(NS3)的复制缺陷型重组腺病毒,为防治HCV感染的基因免疫和基因治疗提供实验基础。方法将HCV NS3基因定向克隆到穿梭质粒pAdTrack-CMV上,经与腺病毒骨架质粒pAdEasy-1在大肠埃希菌BJ5183内同源重组后,转染293细胞进行包装,并反复感染293细胞进行扩增。结果通过PCR扩增、酶切、核酸测序及Western杂交法检测鉴定,均证实插入穿梭质粒中的片段为HCV NS3基因(基因型1b);所包装出的复制缺陷型重组腺病毒AdEasy-GFP-NS3具有良好的感染能力,并可在293细胞中表达HCV NS3蛋白。结论AdEasy-GFP-NS3携带有HCV NS3基因,能有效地感染293细胞并高效表达,从而为丙型肝炎基因疫苗的进一步研究奠定了基础。 OBJECTIVE To construct the replicate-deficient recombinant adenovirus expressing nonstructural protein 3 (NS3) of hepatitis C virus (HCV) for gene therapy against HCV infection. METHODS pAdTrack-NS3 was cloned by inserting the fragment of HCV NS3 into the shuttle plasmid vector pAdTrack-CMV. For getting recombinant adenovirus plasmid (pAdEasy-GFP-NS3), the homologous recombination with pAdTrack-NS3 and the backbone plasmid pAdEasy-1 took place in bacteria BJ5183; then pAdEasy-GFP-NS3 transfected in 293 cells for getting packaged infectious replicate-deficient recombinant adenovirus and were amplified by infecting 293 cells. RESULTS By PCR amplification, restricted enzymatic digestion, DNA sequencing and Western blot, the fragment inserted within pAdTrack-NS3 was certificated as HCV NS3 (genotype 1b). AdEasy-GFP-NS3 could efficiently infect 293 cells and express NS3 protein. CONCLUSIONS Replicate-deficient recombinant adenovirus AdEasy-GFP-NS3 could infect 293 cells and express HCV NS3 protein effectively, which would provide experimental basis for gene immunization against HCV infection.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2005年第9期973-976,共4页 Chinese Journal of Nosocomiology
基金 国家863高技术项目资助(2002AA214161)
关键词 丙型肝炎病毒 非结构蛋白3 重组腺病毒疫苗 基因治疗 Hepatitis C virus Nonstructural protein 3 Recombinant adenovirus vaccine,Gene therapy
  • 相关文献

参考文献13

  • 1Martin P, Parroche P, Chatel L, et al. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen[J]. J Med Virol, 2004, 74(3): 397-405.
  • 2Jiao X, Wang RY, Feng Z, et al. DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Thl type immune response[J]. J Viral Hepat, 2004, 11(1): 18-26.
  • 3Simon BE, Cornell KA, Clark TR, et al. DNA vaccination protects mice against challenge with Listeria monocytogenes expressing the hepatitis C virus NS3 protein[J]. Infect Immun, 2003, 71(11): 6372-6380.
  • 4Isaguliants MG, Petrakova NV, Mokhonov VV, et al. DNA immunization efficiently targets conserved functional domains of protease and ATPase /helicase of nonstructural 3 protein(NS3) of human hepatitis C virus[J]. Immunol Lett, 2003, 88(1): 1-13.
  • 5Inoue H, Nojima H, Okayama H. High efficiency transformation of Escherichia coli with plasmids[J]. Gene, 1990, 96 ( 1 ) :23-28.
  • 6Katznelson S, Wilkinson AH, Kobashigawa JA, et al. The effect of pravastatin on acute re]ection after kidney transplantation-a pilot study[J]. Transplantation, 1996, 61(10) : 1469-1474.
  • 7Lechner F, Wong DK, Dunbar PR, etal. Analysis of successful immune responses in persons infected with hepatitis C virus[J]. J Exp Med, 2000, 191(9): 1499-1512.
  • 8Eckels DD, Wang H, Bian TH, et al. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection[J]. Immunol Rev, 2000, 174(1): 90-97.
  • 9Scognamlglio P, Accapezzato D, Casciaro MA, et al. Presence of effector CD8 + T cells in hepatitis C virusexposed healthy seronegativedonors[J]. J Irnmunol, 1999, 162(11): 6681-6689.
  • 10Brinster C, Muguet S, Lone YC, et al. Different hepatitis C virus nonstructural protein 3 (NS3)- DNA-expressing vaccines induce in HLA-A2. 1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope[J]. Hepatology,2001, 34(6): 1206-1217.

二级参考文献3

共引文献4

同被引文献27

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部